Mukka Proteins Ltd (MUKKA) Financials - Quarterly Results, Profit & Loss, Balance Sheet, Cash Flow Mukka Proteins Ltd reported sales of ₹490 Cr, operating profit of ₹47 Cr (OPM 10%) and net profit of ₹19 Cr for the quarter ended Jun 2026. Figures in ₹ crore, consolidated where available.
MUKKA quarterly results (₹ Cr) Metric Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026 Jun 2026 Sales 149 303 382 171 245 654 381 490 Expenses 140 262 352 157 224 608 347 443 Operating Profit 10 41 29 14 20 45 34 47 OPM 6% 14% 8% 8% 8% 7% 9% 10% Other Income 4 6 4 3 6 8 15 2 Interest 9 11 10 11 13 15 15 16 Depreciation 4 4 3 3 4 4 5 5 Profit before tax 1 33 20 2 9 35 29 27 Tax -40% 19% 30% 33% 26% 21% 26% 32% Net Profit 1 27 14 2 7 27 21 19 EPS in Rs 0.07 0.88 0.45 0.05 0.2 0.79 0.69 0.63
MUKKA profit & loss, annual (₹ Cr) Metric Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026 TTM Sales 770 1,177 1,380 1,006 1,449 1,768 Expenses 723 1,091 1,274 912 1,335 1,622 Operating Profit 48 86 105 95 115 147 OPM 6% 7% 8% 9% 8% 8% Other Income 7 8 19 16 31 31 Interest 10 16 25 37 54 59 Depreciation 9 12 12 14 17 18 Profit before tax 36 66 87 60 75 100 Tax 28% 28% 15% 20% 24% - Net Profit 26 48 74 48 57 74 EPS in Rs 1.1 2 2.34 1.55 1.74 2.31 Dividend Payout 0% 0% 0% 0% 0% -
MUKKA balance sheet (₹ Cr) Metric Mar 2023 Mar 2024 Mar 2025 Sep 2025 Mar 2026 Equity Capital 22 30 30 - 30 Reserves 126 366 411 - 469 Borrowings 262 365 453 - 779 Other Liabilities 166 179 183 - 343 Total Liabilities 575 941 1,076 - 1,621 Fixed Assets 85 85 94 - 194 CWIP 0 0 9 - 30 Investments 21 31 37 - 56 Other Assets 469 825 937 - 1,341 Total Assets 575 941 1,076 - 1,621
MUKKA cash flows (₹ Cr) Metric Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026 Cash from Operating Activity 5 -56 -150 -112 -111 Cash from Investing Activity -11 -3 -48 -35 -146 Cash from Financing Activity 15 75 266 56 267 Net Cash Flow 8 15 68 -91 10 Free Cash Flow -1 -64 -165 -137 -248 CFO/OP 22% -52% -118% -114% -84%
MUKKA ratios Metric Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026 Debtor Days 29 35 49 72 46 Inventory Days 95 89 136 266 267 Days Payable 56 51 44 67 75 Cash Conversion Cycle 68 73 141 272 238 Working Capital Days -1 10 45 99 45 ROCE 18% 24% 19% 12% 12%